RevMedx news

Manufacturer of the revolutionary XSTAT technology will now have a second sterile wound dressing available in Europe and other International markets.

RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. XGAUZE, a Class I sterile multi-layer wound dressing, contains an embedded layer of compressed cellulose sponges that

RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended Limb Tourniquets. The TX series joins the XSTAT® injectable hemostatic on the TCCC list of recommended hemorrhage control devices for casualty care.

Andrew Barofsky, President and CEO of RevMedx, Inc., stated, “We are pleased that yet another RevMedx product is now part of the TCCC gu

Revolutionary bleeding control technology will now be available in Europe and other International markets.

RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe. Unlike traditional wound treatments that may take several minutes to be effective, XSTAT can stop bleeding in seconds to stabilize injuri